Biohaven (BHVN) Other Non-Current Assets (2021 - 2026)
Biohaven (BHVN) posted Other Non-Current Assets of $45.7 million for Q1 2026, down 3.49% sequentially from $47.4 million in Q4 2025, and up 18.39% YoY from $38.6 million in Q1 2025.
Biohaven (BHVN) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Biohaven has reported Other Non-Current Assets for 6 years, with the latest figure at $45.7 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 18.39% year-over-year to $45.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.7 million (up 18.39% YoY) and the FY2025 annual result came in at $47.4 million, up 19.83% from the prior year.
- Other Non-Current Assets eased to $45.7 million in Q1 2026 per BHVN's latest filing, from $47.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $48.2 million in Q3 2025 and troughed at $17.9 million in Q3 2022.
- A 5-year average of $36.7 million and a median of $36.8 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 159.82% in 2022, then declined 9.94% in 2023.
- Over 5 years, Other Non-Current Assets stood at $37.5 million in 2022, then slipped by 9.94% to $33.8 million in 2023, then advanced by 16.99% to $39.5 million in 2024, then gained by 19.83% to $47.4 million in 2025, then retreated by 3.49% to $45.7 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $45.7 million, $47.4 million, and $48.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | 39.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.30 Mn |
| Mar 31, 2026 | 45.71 Mn |
| Dec 31, 2025 | 47.36 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 37.21 Mn |
| Mar 31, 2025 | 38.61 Mn |
| Dec 31, 2024 | 39.53 Mn |
| Sep 30, 2024 | 31.96 Mn |
| Jun 30, 2024 | 32.92 Mn |
| Mar 31, 2024 | 33.31 Mn |
| Dec 31, 2023 | 33.79 Mn |
| Sep 30, 2023 | 34.71 Mn |
| Jun 30, 2023 | 35.55 Mn |
| Mar 31, 2023 | 36.76 Mn |
| Dec 31, 2022 | 37.51 Mn |
| Sep 30, 2022 | 17.88 Mn |
| Dec 31, 2021 | 14.44 Mn |